DOSSIER · 13F-HR · Q1 2026

B Group, Inc.

B's family office based in Omaha, NE $135M in tracked AUM across 20 positions as of Q1 2026.

B
B·Omaha, NE·Family Office
CIK 0002043476 · last filed Mar 31, 2026
Total AUM
$135M
12.3%
vs prior
Holdings
20
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
Top sector
Tech
8% weight
concentration
AI Analysis · Q1 2026 · Q1 2026

Portfolio Overview

B Group, Inc. has undergone a significant transformation in the quarter ending September 30, 2025. The firm executed a substantial reduction in portfolio size, with total assets under management (AUM) plummeting by 50.9%, dropping from $129.94 million to $63.85 million. This drastic capital reduction was accompanied by a shift in concentration; the firm exited eight positions while consolidating capital into a tighter list of 12 holdings. The portfolio is currently highly...

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
ADMA
ADMA BIOLOGICS INC
$29M3.2M21.4%
02
PALI
PALISADE BIO INC
$20M11.4M14.8%
03
PRAX
PRAXIS PRECISION MEDICINES I
$11M33K7.9%
04
CLLS
CELLECTIS S A
$10M3.3M7.7%
05
ZLAB
ZAI LAB LTD
$8M451K6.3%
06
TSHA
TAYSHA GENE THERAPIES INC
$8M1.8M6.0%
07
NRXP
NRX PHARMACEUTICALS INC
$6M3.0M4.7%
08
GPCR
STRUCTURE THERAPEUTICS INC
$6M128K4.6%
09
IOVA
IOVANCE BIOTHERAPEUTICS INC
$5M1.5M3.9%
10
SYRE
SPYRE THERAPEUTICS INC
$5M100K3.7%

Filing history

Filing history loading…